Recombinant Human GRHL1 Protein: Handling & Usage Protocol

Recombinant Human GRHL1 Protein is a research-grade transcription factor used to investigate epithelial differentiation, neural tube development, and grainyhead-like signaling pathways in vitro.

Product SKU

rp376645

Protein Name

Recombinant Human GRHL1 Protein

Protein Family

Grainyhead-like (GRHL) transcription factor family

Recommended Storage

-80°C for long-term storage; avoid repeated freeze-thaw cycles

Primary Application

In vitro biochemical and cell-based assays for transcription factor research

Host/Expression System

Refer to product datasheet (rp376645) for confirmed expression host details

Background: GRHL1 and Its Biological Role

GRHL1 (Grainyhead-like protein 1) is a member of the evolutionarily conserved Grainyhead-like (GRHL) family of transcription factors. These proteins play essential roles in epithelial morphogenesis, barrier function, wound healing, and neural tube closure. GRHL1 contains a characteristic DNA-binding domain and a dimerization domain, enabling it to bind specific promoter elements and regulate the transcription of target genes involved in epithelial differentiation and development.

GRHL1 has been implicated in skin barrier formation, auditory hair cell development, and neural crest cell biology. Dysregulation of GRHL1 expression has been associated with developmental defects and is being explored in cancer biology contexts. Recombinant Human GRHL1 Protein (rp376645) provides researchers with a defined, research-grade tool for studying these pathways in controlled experimental settings.

Reconstitution and Preparation

Prior to use, carefully review the product datasheet supplied with Recombinant Human GRHL1 Protein (rp376645) for lot-specific reconstitution instructions. General best-practice guidelines are described below.

1. Equilibration: Allow the vial to equilibrate to room temperature for approximately 5–10 minutes before opening. Do not heat.
2. Reconstitution buffer: Reconstitute lyophilized protein in the buffer recommended on the datasheet (typically sterile PBS or a carrier-protein-containing buffer such as 0.1% BSA in PBS). Add the reconstitution buffer slowly and gently swirl; do not vortex vigorously, as this may denature the protein.
3. Concentration check: After reconstitution, verify protein concentration using a validated assay (e.g., BCA or Bradford) if downstream application requires precise quantification.
4. Clarification: Briefly centrifuge at low speed (e.g., 300–500 × g for 2 minutes) to pellet any insoluble material before aliquoting.

Note: Specific reconstitution volumes and buffer compositions are provided on the official product datasheet. Always refer to the datasheet for lot-specific guidance.

Storage and Stability

Proper storage is critical to maintaining the activity and integrity of Recombinant Human GRHL1 Protein.

• Short-term storage (≤1 week): Store reconstituted protein at 4°C if it will be used within one week.
• Long-term storage: Aliquot into single-use volumes immediately after reconstitution and store at -80°C. Aliquoting prevents activity loss from repeated freeze-thaw cycles.
• Freeze-thaw cycles: Limit to a maximum of 2–3 freeze-thaw cycles. Each cycle can result in protein aggregation and loss of biological activity.
• Carrier protein: Adding a carrier protein (e.g., 0.1% BSA) to the reconstitution buffer may enhance stability, particularly at low protein concentrations. Confirm compatibility with your assay.

Always consult the product datasheet (rp376645) for confirmed stability data and recommended storage conditions specific to this lot.

Experimental Applications

Recombinant Human GRHL1 Protein is suitable for a range of in vitro research applications. Optimal working concentrations must be determined empirically for each application and experimental system.

• Electrophoretic Mobility Shift Assay (EMSA): Used to study GRHL1 DNA-binding activity and to characterize its interaction with specific promoter sequences.
• In vitro transcription assays: Useful for studying GRHL1-mediated regulation of gene expression in cell-free systems.
• Protein–protein interaction studies: Co-immunoprecipitation or pull-down assays to identify GRHL1 binding partners and dimerization properties.
• Antibody validation: Serves as a positive control antigen for Western blotting or ELISA development targeting GRHL1.
• Structural and biochemical studies: Suitable for biophysical characterization of the GRHL1 protein fold and domain function.

Note: Confirm suitability for your specific application with the product datasheet and perform titration experiments to establish optimal conditions.

Quality Control and Troubleshooting

To ensure reliable experimental results with Recombinant Human GRHL1 Protein, implement the following quality control practices:

• SDS-PAGE verification: Run a small aliquot on SDS-PAGE to confirm protein size and purity before use in critical experiments.
• Activity confirmation: Where functional assays are available, verify biological activity prior to use. Refer to the datasheet for activity assay details specific to rp376645.
• Endotoxin levels: For cell-based assays, confirm that endotoxin levels are within acceptable limits as specified on the product datasheet.

Common troubleshooting issues:

• Protein aggregation: May result from improper reconstitution or freeze-thaw cycling. Centrifuge briefly before use and ensure correct buffer composition.
• Reduced activity: Could indicate protein degradation due to improper storage. Check storage records and use a fresh aliquot.
• Non-specific bands on Western blot: Optimize antibody concentrations and confirm protein concentration used as standard.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human GRHL1 Protein?

The recommended reconstitution buffer is specified on the product datasheet for rp376645. In general, sterile PBS or PBS containing 0.1% BSA as a carrier protein is commonly used for recombinant transcription factor proteins. Always follow the lot-specific datasheet instructions for best results.

How should Recombinant Human GRHL1 Protein be stored to maintain activity?

For long-term storage, aliquot the reconstituted protein and store at -80°C. Avoid repeated freeze-thaw cycles, as each cycle may cause aggregation and loss of biological activity. For short-term use within one week, storage at 4°C is acceptable. Consult the product datasheet for confirmed stability data.

What experimental applications is Recombinant Human GRHL1 Protein suitable for?

Recombinant Human GRHL1 Protein (rp376645) is suitable for in vitro applications including EMSA (DNA-binding studies), in vitro transcription assays, protein-protein interaction studies, antibody validation (e.g., Western blot positive control), and structural or biochemical characterization. Optimal concentrations should be determined empirically for each application.

How many freeze-thaw cycles can Recombinant Human GRHL1 Protein tolerate?

As a general guideline for recombinant proteins, it is recommended to limit freeze-thaw cycles to no more than 2–3 times. Excessive freeze-thaw cycling can lead to protein aggregation and reduced biological activity. Aliquoting into single-use volumes before freezing is strongly recommended.

Is Recombinant Human GRHL1 Protein suitable for cell-based assays?

Recombinant Human GRHL1 Protein may be used in cell-based assay contexts; however, endotoxin levels must be confirmed to be within acceptable limits before use in cell culture. Refer to the product datasheet (rp376645) for endotoxin specification and any additional notes on cell-based compatibility.

References

1. Wilanowski T, et al. Perturbed desmosomal cadherin expression in grainyhead-like 1-null mice. Eur J Cell Biol. 2008.
2. Ting SB, et al. A homolog of Drosophila grainyhead is essential for epidermal integrity in mice. Science. 2005.
3. Mlacki M, et al. Loss of Grainyhead-like 1 is associated with disruption of the epidermal barrier. PLoS ONE. 2014.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.